ARGOLINI, LORENZA MARIA
ARGOLINI, LORENZA MARIA
Universita' degli Studi di MILANO
Anti-SARS-CoV-2 vaccination in adolescent and adult patients with juvenile-onset systemic lupus erythematosus: tolerability and impact on disease activity
2023 C.B. Chighizola, I. Suardi, G. Carrea, L. Argolini, M. Gattinara, A. Marino, I. Pontikaki, R. Caporali, M. Gerosa
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
2023 G.A. Ramirez, M. Gerosa, C. Bellocchi, D. Arroyo-Sánchez, C. Asperti, L.M. Argolini, G. Gallina, M. Cornalba, I. Scotti, I. Suardi, L. Moroni, L. Beretta, E.P. Bozzolo, R. Caporali, L. Dagna
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort
2022 M. Gerosa, L. Beretta, G.A. Ramirez, E. Bozzolo, M. Cornalba, C. Bellocchi, L.M. Argolini, L. Moroni, N. Farina, G. Segatto, L. Dagna, R. Caporali
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination
2022 G.A. Ramirez, L.M. Argolini, T. Schioppo, S. Sciascia, L. Moroni, G. Moroni, R.A. Sinico, G. Bonelli, F. Alberici, F. Mescia, F. Tamborini, P. Miraglia, C. Bellocchi, L. Beretta, D. Roccatello, E.P. Bozzolo, R. Caporali, M. Gerosa, L. Dagna
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study
2022 M. Gerosa, T. Schioppo, L.M. Argolini, S. Sciascia, G.A. Ramirez, G. Moroni, R.A. Sinico, G. Bonelli, F. Alberici, F. Mescia, L. Moroni, F. Tamborini, P. Miraglia, C. Bellocchi, L. Beretta, D. Roccatello, L. Dagna, E. Bozzolo, R. Caporali
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology
2022 A. Manfredi, G. Cassone, R. Izzo, G. Dallagiacoma, M. Felicetti, A. Cariddi, A. Berti, A. Giollo, C. Nannini, S. Bettio, S. Monti, E. Conticini, M. Govoni, L. Quartuccio, L.M. Argolini, S. Kaleci, G. Emmi, C. Dejaco, R. Padoan, L. Dagna, M. Rossini, F. Cantini, C. Montecucco, B. Frediani, S. De Vita, R. Caporali, F. Muratore, M. Sebastiani, C. Salvarani
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
2022 T. Schioppo, L.M. Argolini, S. Sciascia, F. Pregnolato, F. Tamborini, P. Miraglia, D. Roccatello, R.A. Sinico, R. Caporali, G. Moroni, M. Gerosa
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up
2020 L.M. Argolini, G. Frontini, E. Elefante, F. Saccon, V. Binda, C. Tani, I. Scotti, L. Carli, M. Gatto, C. Esposito, M. Gerosa, R. Caporali, A. Doria, P. Messa, M. Mosca, G. Moroni
The use of biologics and small molecules in pregnant patients with rheumatic diseases
2018 M. Gerosa, L.M. Argolini, C. Artusi, C.B. Chighizola
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
2016 E. Nuri, M. Taraborelli, L. Andreoli, M. Tonello, M. Gerosa, A. Calligaro, L.M. Argolini, R. Kumar, V. Pengo, P.L. Meroni, A. Ruffatti, A. Tincani